Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
Lynnette Hunter of AbelsonTaylor Group on Empowering Women in the Workforce | Muse by Clio
During Women’s History Month, Lynnette Hunter, EVP, Director of Client Services, speaks about women's leadership at AT Group.
In the News Read more Lynnette Hunter of AbelsonTaylor Group on Empowering Women in the Workforce | Muse by ClioArtificial Intelligence and DTC Marketing: The Real Opportunities – Xpectives.Health
Sharlene Jenner, VP, Director of Engagement, talks about ways pharma marketers can use AI to enhance DTC marketing.
In the News Read more Artificial Intelligence and DTC Marketing: The Real Opportunities – Xpectives.HealthAbelsonTaylor Group Names Lane Degenhart as Vice President, Account Director – PharmaLive
Lane Degenhart, a 20-year pharmaceutical marketing veteran with diverse oncology and rare disease experience, joins AT Group.
In the News Read more AbelsonTaylor Group Names Lane Degenhart as Vice President, Account Director – PharmaLiveConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.
